Common signs of malignancy (1) Visible opacity disrupting breast architecture (2) Dense opacity with: spiculation nodulation tentacles 'mare's tail'
(3) Clinical size greater than radiological size (4) Fine calcification in or near tumour (30%Y.): punctate=scirrhous 'broken ends ofneedles' suggests duct carcinoma (5) Alteration in breast contour: nipple retraction skin thickening and dimpling large vessels obliteration ofpectoral line lumen of the ducts by products of secretion is a prominent feature. Carcinoma: The radiological features of a carcinoma of the breast are shown in Table 2 . Visible opacity: Tumour tissue, whether carcinomatous or sarcomatous, has the same density as normal tissue but by virtue of the fat content of the breast the tumour becomes visible on the plain film. In the large fat-infiltrated breast the tumour may be readily visible for the above reasons but in the glandular breast it may be difficult to differentiate the tumour mass from the normal gland structure. In pregnancy, when the glandular structure is active, the differentiation of tumour from glandular structure is less clearly seen and it may not be possible to differentiate quite large tumours from gland structure.
Tumour margin: The outline of a malignant tumour characteristically shows a spiculated outline and when this is defined the diagnosis can be made with reasonable confidence (Fig 2) . However, this spiculated outline is not necessarily present and certain carcinomata may show a smooth or lobulated outline.
Host reaction: Cysts and benign tumours such as fibroadenoma show a clear-cut, well-defined outline with a thin line representing compressed breast tissue(lignede securite) (Fig 1) . This finding may be particularly valuable in cases where there are multiple areas of mastitis present in the area around the cyst. Leborgne rule: Leborgne (1953) pointed out that the palpable tumour as measured clinically was much larger than that demonstrated radiologically. This is in contrast to benign tumours, where the size of the mass and the radiological size correspond (Fig 2) .
Calci.fication: Calcification was demonstrated in 29 out of 74 (39%Y.) of the growths examined in this series. Pathologically calcificationwas demonstrated in a considerably higher proportion and calcification could be seen in almost 50 % of cases. The radiological features of calcification in breast carcinoma is characteristically spiculated and has a 'broken needle' appearance. This type of calcification is apparently specific and we have not found it in any other breast tumours. Calcification can occur in other nonmalignant breast conditions and has been reported in 7 % of fibroadenomata and in 17% of mammary dysplasias (Fig 1) . The calcification, however, does not show the spiculated appearance of carcinoma. Calcification in arterial branches can also be noted in the elderly but the appearances of the calcification are similar to vascular calcification in other parts of the body. Alterations in breast contour: The features of dimpling of the skin noted clinically can be seen radiologically. The extension of the tumour towards the nipple can frequently be seen as a prolongation of soft tissue towards the nipple, representing extension of the growth towards the nipple. This has been descriptively called a 'mare's tail' appearance. In our experience we have found this 'mare's tail' appearance of the tumour characteristic of malignancy. REFERENCE Leborgne R (1953) 
Some Aspects of Mammogaphy
Accuracy of diagnosis: A high degree of accuracy is claimed by most workers. Table 1 indicates the diagnostic accuracy in consecutive series of mammograms. The list is comparative and by no means comprehensive. The figures in the first column between 80% and 89 % seem to correspond to an accuracy rate in our consecutive series of mammograms of 89 %, i.e. with normals included and in which all equivocal reports and all errors are counted as wrong. In the second column only outright mistakes appear to have Egan (1963) 2,000 97% Royal Infirmary, Edinburgh (1963) 300 89% 94% been counted. In our series, the correspornding accuracy figure would be 94%. It seems, therefore, that an accuracyrate ranging between 80 % and 98 % is generallyfound, depending on how equivocal reports are counted.
A further breakdown can be made from our series in the Royal Infirmary at Edinburgh. Of our 300 cases, 138 are not proven, and the rest have biopsy, metastatic or post-mortem control. For every 100 proven cases, 81 have been correctly diagnosed, 9 wrongly diagnosed, and in 10 cases the reports have been equivocal. Dr J W Black did the bulk of the biopsy reporting in these cases and these figures are from our joint account (Table 2) . It is not easy to assess clinical accuracy in the diagnosis of breast tumours, and there is surprisingly little material published on the subject. Massie & McClelland (1960) analysed 1,500 breast biopsies. They found that clinical accuracy was 80% when only frank errors were counted. If equivocal diagnoses were included, the accuracy rate dropped to 62%. In another shorter series from Glasgow (Sandison 1958) , in 100 cases the accuracy rate by the surgeon before operation was 75 % whereas at operation it rose to between 88 % and 91 %. Mr W A Adamson, of the Royal Infirmary, Edinburgh, to whom we are indebted for a large number of our cases, in a recent survey of his cases estimates his clinical accuracy at 79%. The series of breast lesions, all with biopsy control, covers the years 1953-63 and totals 479 cases (Adamson 1963, personal communication).
It seems that clinical accuracy varies considerably from clinician to clinician but is about 70-75%. The factors involved in the variation must be personal and due to the manner of selection of patients.
Comparison with other radiological procedures is easier. Table 3 shows some recent comparative figures on barium series and neurological procedures. The accuracy rates in mammography seem to be very similar in range to the other accepted radiological examinations.
Ingleby & Gershon-Cohen (1960) say that if the two examinations are made the addition of clinical and radiological data adds considerablyto (Fig 2, p 771 ) (4) Intermediate and mixed types (19 %). It appears that these types vary in degree of malignancy and possibly in rates of growth. According to Ingleby & Gershon-Cohen (1960) the ductal type grows slowly and metastasizes late, but this is not generally accepted and it may be that the relatively good prognosis of this type of carcinoma is due to its being at an early stage of development and still largely confined to the ducts. The prognosis of a well-circumscribed carcinoma, whether of the medullary type or not, appears clearly better than the stellate or so-called scirrhous type (Lane et al. 1961 , Ingleby & Gershon-Cohen 1960 . This classification does not include some of the less common types of carcinoma but some of these also can be identified radiologically so that pre-operative prognosis can be entertained. Mucoid or gelatinous carcinomas can usually be identified by their translucent areas. As is well known, they carry a relatively good prognosis (Foot 1961) .
The so-called 'inflammatory' carcinomata can be identified radiologically often at an earlier stage when there is still clinical doubt as to the nature of the lesion (Berger 1962) . About 2% of all carcinomata fall into this category (Barber et al. 1961 , Berger et al. 1959 ). These tumours are not, as is often thought, commonly associated with pregnancy. They seem to be mainly extremely rapidly growing carcinomata. Leborgne (1953) preferred to call them cedematous carcinomata and the French workers also used this term (Surmont et al. 1961) . They have shown that there is a very poor prognosis attached to the finding of aedema with a carcinoma and also that the cedema is often seen earlier radiologically than clinically.
Bilateral carcinoma is not uncommon. They appear to occur in 2-3% of cases (Cutler 1961 , Picard 1958 , Egan 1963 . Although some of these may be metastatic, Cutler (1961) estimates that no more than half can be so.
Carcinoma in the contralateral breast is often missed clinically in its earlier stages. Adequate mammograms will nearly always show it. Routine mammograms of all remaining breasts after mastectomy are now carried out in several centres.
Unsuspected Carcinomata
For years the average clinical size of the tumour when the woman reports herself with it seems to have varied little from about 3 cm, although there is some variation of this size from centre to centre. From retrospective studies made by plotting 'doubling time' it appears that carcinoma of the breast, in the fast-growing type, reaches approximately half its life span and the size of a little over 1 cm in two to four years, and in the slower growing types in anything up to twelve years (Collins et al. 1956 , McWhirter 1957 . These figures are controversial and not accepted by all authorities.
It seems that a tumour of 1 cm in diameter is the minimal size of tumour which can be palpated in the breast. In lumpy breasts and with an unskilled examiner, the size would probably be much larger. The point is that it is tumours of this size, i.e. 1 cm in diameter at a minimum, which were called 'early', and on which doubts of efficacy of early treatment were expressed (Park & Lees 1951 , Sutherland 1960 , McKinnon 1955 . But when we talk of 'early' lesions found as unsuspected car-cinomata the reference is to breast tumours very much smaller than 1 cm in diameter. Both Gershon-Cohen and Egan haveshown asymptomatic, nonpalpable carcinomata which must be only a few millimetres in size. Such carcinomata reveal themselves as small clusters of minute calcifications, as a small spiculated opacity or as a small lobulated opacity going beyond the confines of a duct. In fatty, atrophic breasts, which fortunately occur commonly in the cancer-bearing age, these signs can be picked up.
A question to be considered is: What is the incidence of unsuspected carcinomata in the population at risk?
In an analysis of 1,500 breast biopsies in which there were 619 carcinomata Massie & McClelland (1960) state that 2-4 % were unsuspected. Smithers (1957) has stated that for every 100 women who reach the age of40 years 3 will die from carcinoma of the breast. It may be that some women die with carcinomata which -are never diagnosed (Mc-Whirter 1957) , but if the figure of 3 % is correct it is rational to expect a 1 % yield by X-raying asymptomatic breasts in women over 40. Bearing in mind the slow growth of the average tumour, repeat X-rays at six-monthly or yearly intervals seem reasonable and would increase the yield of cases. Gershon-Cohen (1961) reports such a survey. He X-rayed regularly every six months 1,055 women over the age of 35 who had no clinical breast lesions. Twenty-three carcinomata (2%) were identified; 17 of these (70%) were stage 1 having no axillary involvement.
Another aspect of survey work in this field is of interest. The Medical Research Council (1962) are at present conducting a survey in Guernsey. It appears that women who are growing carcinoma in their breasts secrete subnormal amounts of certain steroids in their urine. Although it appears from more recent work that this abnormality in steroid secretion only applies to a proportion of cases with carcinoma (Bulbrook et al. 1962 ) a screening examination of this nature, if combined with mammography, might be practical in a mass survey for the detection of early carcinoma of the breast.
In Edinburgh we have only made a start in attempting to discover unsuspected carcinomata. Dr Clifford Kennedy and his colleagues, whose helpful co-operation we gratefully acknowledge, have been sending us women from their wards for X-ray of the breast. We have examined just over a hundred. A number of benign lesions have come to light but there are 2 whose lesions may be more sinister. Neither of these has as yet come to biopsy.
It seems, therefore, that the diagnosis of preclinical unsuspected carcinoma by radiological methods is feasible; that the expected pick-up rate would lie between 1 % and 2 %; and that the organization of such preventive work technically, especially if hormone screening tests were available, is possible. From the clinical viewpoint, we have to define the use of mammography and its value in the management of the individual patient. The radiographic and the pathological features of breast disease are beautifully illustrated in the contributions of Leborgne (1953) and of Ingleby & Gershon-Cohen (1960) and it is obvious that they have given the procedures an intriguing start.
To the clinician mammography is useful in three circumstances:
(1) When other methods of diagnosis leave doubt as to the exact nature of a 'tumour'. Here mammography is of immense value. In the future it may even supersede the need for biopsy; so far, however, I feel the histologist must still be asked to provide frozen section reports.
(2) It may possibly be valuable in the preexcisional classification of breast tumours into 'irregular' (and poorer prognosis) and 'welldelineated' (and better prognosis) groups. At the moment the assessment of each patient with this disease is difficult and, as more and more evidence is forthcoming, we are slowly realizing that no two tumours are alike. Possibly the well-localized lesion could quite logically be treated by local excision and the more radical procedures be reserved for the more irregular growths; the only possible way of differentiating these lesions pre-operatively is by X-ray.
(3) The most attractive use of mammography is undoubtedly in the exciting discovery of very early casesalmost pre-clinical cancersby screening patients. Because of time and expense, some selection would initially have to be usedperhaps blood relations of sufferers from the disease, or women who for some reason have been noted to have a delayed menopause, or any who have been found to have abnormal steroid output. There is also obvious value in regularly examining the remaining breast after mastectomy for carcinoma, and this precaution would be worth starting now.
Mr Peter Holmes
(Royal Sussex County Hospital, Brighton)
During the three-year period 1960-63 over 400 patients have been examined and radiographs taken of both breasts. The clinical, radiological and, when possible, the pathological findings have been correlated.
The technical details are as follows:
Machine: Converted Newton Victor D3, no ifitration.
Tube-film distance: 50 cm. Focal spot: 1 mm (0 5 mm spot would give better results).
Exposure: 50 mA sec at kV 36-48. The lower figure is used for fat breasts in older patients, the higher figure for younger patients with dense breast tissue. Films: After experimenting with several varieties, Ilford Industrial B have been selected as giving the best definition.
